Issaquah, WA, United States of America

Ellen S Dieken

This inventor holds 1 USPTO granted patent. Top assignee: Fred Hutchinson Cancer Center. Active years: 1996.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ellen S Dieken: Innovator in Avian/Mammalian Microcell Hybrids

Introduction

Ellen S Dieken is a prominent inventor based in Issaquah, WA (US). She has made significant contributions to the field of biotechnology, particularly in the development of avian/mammalian microcell hybrids. Her innovative work has implications for genetic research and therapeutic applications.

Latest Patents

Ellen S Dieken holds a patent for "Recombination-proficient avian/mammalian microcell hybrids." This patent describes an avian/mammalian microcell hybrid immortalized pre B cell line that contains a mammalian chromosome carrying a selectable marker. This hybrid cell line can be utilized for introducing predetermined point mutations into specific mammalian chromosomal loci via high-frequency homologous recombination. She has 1 patent to her name.

Career Highlights

Ellen is affiliated with the Fred Hutchinson Cancer Center, where she conducts her research. Her work at this esteemed institution has allowed her to explore innovative solutions in the field of cancer research and genetic engineering.

Collaborations

Ellen has collaborated with notable colleagues, including Mark T Groudine and R E Fournier. These partnerships have enhanced her research and contributed to advancements in their shared field of study.

Conclusion

Ellen S Dieken's contributions to biotechnology through her patent and research at the Fred Hutchinson Cancer Center highlight her role as an influential inventor. Her work continues to pave the way for future innovations in genetic research and therapeutic applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…